#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor IX deficiency Ventricular fibrillation Burkitt's lymphoma Malignant oligodendroglioma Congenital growth hormone deficiency Synovial sarcoma recurrent Urea cycle disorder Haemolytic uraemic syndrome Spinal cord injury Malformation venous Gastrointestinal cancer metastatic Hepatobiliary cancer Synovial sarcoma metastatic Retinal artery occlusion Primary amyloidosis More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma Myxofibrosarcoma – Basic Information Focal segmental glomerulosclerosis – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Cholangitis sclerosing – Diagnostics Leiomyosarcoma recurrent – Life with Disease KBG syndrome Factor IX deficiency – Trials in Disease Haemophilia B without inhibitors – Diagnostics Primary hyperoxaluria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexamethasone Acetate Ph. Eur. Mitoxantrone Hydrochloride Serpina1(Human)-Aav8-1 Pacritinib Sodium Hyaluronate Amikacin Escitalopram Lutetium (177Lu) Oxodotreotide Cytarabine Azd8630 Carvedilol Macrogol 4000 Paclitaxel Albumin-Bound Sulfamethizole Cemiplimab Pralatrexate PARECOXIB Mitoxantrone Terbinafine Ro7790121 More therapies…

    Learn about Your Condition

    Multiple system atrophy Vulvovaginal pruritus Biliary tract disorder Breast neoplasm Corneal graft rejection Gallbladder cancer Pericarditis Tubulointerstitial nephritis Tumour of ampulla of Vater Mixed-type liposarcoma Tuberous sclerosis complex Pulmonary tuberculosis Neurofibromatosis Iron overload Diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Marien Hospital Herne Universitätsklinikum der Ruhr-Universität…

Marien Hospital Herne Universitätsklinikum der Ruhr-Universität Bochum

Hmaaqfxpipdfjc 4de Hplous 4vlsrn Gogykkn

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    • Pirtobrutinib
    • Venetoclax
    Austria Belgium Czechia Denmark Finland France +8

  • Study of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Saruparib
    • Abiraterone Acetate
    • Darolutamide
    Austria Belgium Finland France Germany Hungary +5

  • Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Ipilimumab
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Nivolumab
    Austria Belgium France Germany Italy Poland +1

  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Erdafitinib
    • Gemcitabine Hydrochloride
    • Mitomycin
    Austria Belgium Czechia Denmark France Germany +4

  • Study on the Effect of Acyclovir in ICU Patients with Pneumonia and Herpes Simplex Virus Type 1 Detected in Lung Fluid

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes simplex
    Investigated Drugs:
    • Aciclovir
    Germany

  • Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Daunorubicin
    • Cytarabine
    • Venetoclax
    Austria Belgium Estonia Finland Germany Lithuania +2

  • Study on the Effectiveness of Oxaliplatin, Docetaxel, and Fluorouracil in Patients with Resectable Gastric and Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Cisplatin
    • Docetaxel
    Germany

  • Randomized trial of irinotecan drug combination versus standard therapy as first-line treatment in patients with locally advanced or metastatic small bowel adenocarcinoma

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Calcium Folinate
    • Fluorouracil
    Germany

  • Colchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Colchicine
    Germany

  • BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    • Prostate cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • BMS-986365
    Germany
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!